Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.
3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece. Electronic address: nmiaris@gmail.com.
Nikolaos
N
Miaris
Department of Neurology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.
Maria
M
Maltezou
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
George
G
Papaxoinis
3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.
Anastasios
A
Visvikis
3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.
Epaminontas
E
Samantas
D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D000068338:Everolimus / Q000008:administration & dosage / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D007191:Indazoles / Q000008:administration & dosage / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000139:chemically induced*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects
D007093:Imidazoles; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib; D000068338:Everolimus; D000077784:Axitinib
Anti-VEGF agents; Proteinuria; Renal carcinoma; Reversible posterior leukoencephalopathy syndrome; Tyrosine kinase inhibitors